The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome
Abstract
Objective: To date, 3 rare missense mutations in the SNCA (α‐synuclein) gene and the more frequent duplications or triplications of the wild‐type gene are known to cause a broad array of clinical and pathological symptoms in familial Parkinson disease (PD). Here, we describe a French family with a parkinsonian–pyramidal syndrome harboring a novel heterozygous SNCA mutation. Methods: Whole exome sequencing of DNA from 3 patients in a 3‐generation pedigree was used to identify a new PD‐associated mutation in SNCA. Clinical and pathological features of the patients were analyzed. The cytotoxic effects of the mutant and wild‐type proteins were assessed by analytical ultracentrifugation, thioflavin T binding, transmission electron microscopy, cell viability assay, and caspase‐3 activation. Results: We identified a novel SNCA G51D (c.152 G>A) mutation that cosegregated with the disease and was absent from controls. G51D was associated with an unusual PD phenotype characterized by early disease onset, moderate response to levodopa, rapid progression leading to loss of autonomy and death within a few years, marked pyramidal signs including bilateral extensor plantar reflexes, occasionally spasticity, and frequently psychiatric symptoms. Pathological lesions predominated in the basal ganglia and the pyramidal tracts and included fine, diffuse cytoplasmic inclusions containing phospho‐α‐synuclein in superficial layers of the cerebral cortex, including the entorhinal cortex. Functional studies showed that G51D α‐synuclein oligomerizes more slowly and its fibrils are more toxic than those of the wild‐type protein. Interpretation: We have identified a novel SNCA G51D mutation that causes a form of PD with unusual clinical, neuropathological, and biochemical features. Ann Neurol 2013;73:459–471
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Schuck, P. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76713-0 · Cited by 3,868
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
Giasson, B. I., Murray, I. V. J., Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008919200 · Cited by 1,080
Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease
Ibáñez, P., Bonnet, A.-M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,044
Self-citationSpira, P. J., Sharpe, D. M., Halliday, G., Cavanagh, J., & Nicholson, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.67 · Cited by 627
(2004) · doi:10.1002/ana.10846 · Cited by 614
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication
Fuchs, J., Nilsson, C., Kachergus, J., Munz, M., Larsson, E.-M., Schüle, B., Langston, J. W., Middleton, F. A., Ross, O. A., Hulihan, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000254458.17630.c5 · Cited by 397
Spira, P. J., Sharpe, D. M., Halliday, G. M., Cavanagh, J., & Nicholson, G. A. (2001) · PubMed · Cited by 343
Genomic investigation of α‐synuclein multiplication and parkinsonism
Ross, O. A., Braithwaite, A. T., Skipper, L. M., Kachergus, J., Hulihan, M. M., Middleton, F. A., Nishioka, K., Fuchs, J., Gasser, T., Maraganore, D. M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21380 · Cited by 342
Genome-wide Linkage Analysis of a Parkinsonian-Pyramidal Syndrome Pedigree by 500 K SNP Arrays
Shojaee, S., Sina, F., Banihosseini, S. S., Kazemi, M. H., Kalhor, R., Shahidi, G.-A., Fakhrai-Rad, H., Ronaghi, M., & Elahi, E. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.05.005 · Cited by 258
Fibrillar α-Synuclein and Huntingtin Exon 1 Assemblies Are Toxic to the Cells
Pieri, L., Madiona, K., Bousset, L., & Melki, R. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.04.050 · Cited by 248
Self-citationFamilial parkinsonism with synuclein pathology: Clinical and PET studies of A30P mutation carriers
Krüger, R., Kuhn, W., Leenders, K. L., Sprengelmeyer, R., Müller, T., Woitalla, D., Portman, A. T., Maguire, R. P., Veenma, L., Schröder, U., et al. (2001) · Neurology · doi:10.1212/wnl.56.10.1355 · Cited by 167
Association between cardiac denervation and parkinsonism caused by α‐synuclein gene triplication
Singleton, A., Gwinn, K. A., Sharabi, Y., Li, S., Holmes, C. S., Dendi, R., Hardy, J., Singleton, A., Crawley, A., & Goldstein, D. S. (2004) · Brain · doi:10.1093/brain/awh081 · Cited by 147
Expanding the clinical phenotype of SNCA duplication carriers
Nishioka, K., Ross, O. A., Ishii, K., Kachergus, J. M., Ishiwata, K., Kitagawa, M., Kono, S., Obi, T., Mizoguchi, K., Inoue, Y., et al. (2009) · Movement Disorders · doi:10.1002/mds.22682 · Cited by 147
Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10
Goizet, C., Boukhris, A., Mundwiller, E., Tallaksen, C. M. E., Forlani, S., Toutain, A., Carrière, N., Paquis, V., Depienne, C., Dürr, A., et al. (2008) · Human Mutation · doi:10.1002/humu.20920 · Cited by 137
Self-citationClinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson’s disease
Markopoulou, K., Dickson, D. W., McComb, R. D., Wszołek, Z. K., Katechalidou, L., Avery, L. L., Stansbury, M. S., & Chase, B. A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0372-4 · Cited by 110
First appraisal of brain pathology owing to A30P mutant alpha‐synuclein
Seidel, K., Schöls, L. J., Nuber, S., Petrasch‐Parwez, E., Gierga, K., Wszołek, Z. K., Dickson, D. W., Gai, W., Bornemann, A., Rieß, O., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21966 · Cited by 110
A Swedish family with de novo α-synuclein A53T mutation: Evidence for early cortical dysfunction
Puschmann, A., Ross, O. A., Vilariño‐Güell, C., Lincoln, S., Kachergus, J. M., Cobb, S. A., Lindquist, S. G., Nielsen, J. E., Wszołek, Z. K., Farrer, M. J., et al. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.06.007 · Cited by 105
PA700, the regulatory complex of the 26S proteasome, interferes with α‐synuclein assembly
Ghee, M., Melki, R., Michot, N., & Mallet, J. J. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04776.x · Cited by 97
Self-citationCLINICOPATHOLOGIC STUDY OF A SNCA GENE DUPLICATION PATIENT WITH PARKINSON DISEASE AND DEMENTIA
Obi, T., Nishioka, K., Ross, O. A., Terada, T., Yamazaki, K., Sugiura, A., Takanashi, M., Mizoguchi, K., Mori, H., Mizuno, Y., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000299387.59159.db · Cited by 85
Alpha‐synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients
Berg, D., Niwar, M., Maaß, S., Zimprich, A. A., Möller, J. C., Wüllner, U., Schmitz‐Hübsch, T., Klein, C., Tan, E., Schöls, L. J., et al. (2005) · Movement Disorders · doi:10.1002/mds.20504 · Cited by 75
The Ala53Thr mutation in the α‐synuclein gene in a Korean family with Parkinson disease
Ki, C., Stavrou, E., Davanos, Ν., Lee, W., Chung, E., Kim, J., & Athanassiadou, A. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00781.x · Cited by 73
Papapetropoulos, S., Ellul, J., Paschalis, C., Athanassiadou, A., Papadimitriou, A., & Papapetropoulos, T. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00576.x · Cited by 27
Letournel, F., Bocquet, A., Dubas, F., Barthelaix, A., & Eyer, J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1211 · Cited by 26
Self-citation
Cited by
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
A new era for understanding amyloid structures and disease
Iadanza, M. G., Jackson, M. P., Hewitt, E. W., Ranson, N. A., & Radford, S. E. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0060-8 · Cited by 980
Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein
Tuttle, M. D., Comellas, G., Nieuwkoop, A. J., Covell, D. J., Berthold, D. A., Kloepper, K. D., Courtney, J. M., Kim, J. K., Barclay, A. M., Kendall, A., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3194 · Cited by 959
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Wong, Y. C., & Krainc, D. (2017) · Nature Medicine · doi:10.1038/nm.4269 · Cited by 897
Bendor, J. T., Logan, T. P., & Edwards, R. H. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.004 · Cited by 825
Metadata
- Authors
- Lesage, S., Anheim, M., Letournel, F., Bousset, L., Honoré, A., Rozas, N., Pieri, L., Madiona, K., Dürr, A., Melki, R., Verny, C., Brice, A., & for the French Parkinson's Disease Genetics Study Group
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2013-04
- Volume
- 73
- Issue
- 4
- Pages
- 459-471
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1815242288
- Cited by
- 711
- References
- 33
- FWCI
- 30.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.